–
February 16, 2022
![](https://www.nanomedicines.ca/wp-content/uploads/2022/01/CQDM_Webinar_No2.jpg)
CQDM is proud to present a new series of webinars: The Evolving Landscape of AI Implementation in New Drug Discovery & Development.
In the second event of the series Philip Tagari, VP of Research (Therapeutic Discovery), Amgen will host a panel of leading pharmaceutical and artificial intelligence executives to discuss the topic:
Generation of Innovative Therapeutics using Artificial Intelligence.